Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun An experimental nucleoside reverse transcriptase inhibitor for the treatment of HIV.

Etymologies

Sorry, no etymologies found.

Support

Help support Wordnik (and make this page ad-free) by adopting the word elvucitabine.

Examples

  • Achillion has completed midstage tests of elvucitabine in both hepatitis B and HIV.

    daytondailynews.com - News 2010

  • Terms were not disclosed, but the companies said GCA will have the right to develop and sell elvucitabine in China, Hong Kong, and Taiwan through a joint venture with Tianjing Institute of Pharmaceutical Research.

    daytondailynews.com - News 2010

  • She believes that partnership would be more important than the elvucitabine agreement for now.

    daytondailynews.com - News 2010

  • NEW YORK - Shares of Achillion Pharmaceuticals Inc. advanced Tuesday after the company said it entered a partnership to develop and sell its hepatitis B and HIV drug candidate elvucitabine in China and other territories.

    daytondailynews.com - News 2010

  • Terms were not disclosed, but the companies said GCA will have the right to develop and sell elvucitabine in China, Hong Kong, and Taiwan through a joint venture with Tianjing Institute of Pharmaceutical Research.

    daytondailynews.com - News 2010

  • She believes that partnership would be more important than the elvucitabine agreement for now.

    daytondailynews.com - News 2010

  • Achillion has completed midstage tests of elvucitabine in both hepatitis B and HIV.

    daytondailynews.com - News 2010

  • NEW YORK - Shares of Achillion Pharmaceuticals Inc. advanced Tuesday after the company said it entered a partnership to develop and sell its hepatitis B and HIV drug candidate elvucitabine in China and other territories.

    daytondailynews.com - News 2010

  • The decline in research and development expenses is related to a decrease in outsourced research costs, specifically related to clinical trial costs for elvucitabine and preclinical trial costs for ACH-1625 and ACH-702, each of which is now completed but which were ongoing in 2008.

    News 2009

  • The decline in research and development expenses is related to a decrease in outsourced research costs, specifically related to clinical trial costs for elvucitabine and preclinical trial costs for ACH-1625 and ACH-702, each of which is now completed but which were ongoing in 2008.

    News 2009

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.